U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Stage B Chronic Lymphocytic Leukemia

MedGen UID:
1643006
•Concept ID:
C4683623
•
Neoplastic Process

Definition

Findings: Lymphocytosis and adenopathy; Survival (months): 95. (from AJCC 8th Ed.) [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVStage B Chronic Lymphocytic Leukemia

Professional guidelines

PubMed

Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.
Montserrat E, Villamor N, Urbano-Ispizua A, Ribera JM, Lozano M, Vives-Corrons JL, Rozman C
Ann Hematol 1991 Jul;63(1):15-9. doi: 10.1007/BF01714955. PMID: 1878419

Recent clinical studies

Etiology

A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Blood 1990 Apr 1;75(7):1422-5. PMID: 2180493
CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978) 1988;30(5-6):449-52. PMID: 2906118

Diagnosis

Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.
Montserrat E, Villamor N, Urbano-Ispizua A, Ribera JM, Lozano M, Vives-Corrons JL, Rozman C
Ann Hematol 1991 Jul;63(1):15-9. doi: 10.1007/BF01714955. PMID: 1878419

Therapy

Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia.
Takahashi F, Ogawa Y, Hasebe N, Natori S, Tokusashi Y, Miyokawa N, Kikuchi K
Intern Med 2000 Mar;39(3):256-9. doi: 10.2169/internalmedicine.39.256. PMID: 10772132
Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.
Montserrat E, Villamor N, Urbano-Ispizua A, Ribera JM, Lozano M, Vives-Corrons JL, Rozman C
Ann Hematol 1991 Jul;63(1):15-9. doi: 10.1007/BF01714955. PMID: 1878419
A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Blood 1990 Apr 1;75(7):1422-5. PMID: 2180493
CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978) 1988;30(5-6):449-52. PMID: 2906118

Prognosis

A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Blood 1990 Apr 1;75(7):1422-5. PMID: 2180493

Clinical prediction guides

Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia.
Takahashi F, Ogawa Y, Hasebe N, Natori S, Tokusashi Y, Miyokawa N, Kikuchi K
Intern Med 2000 Mar;39(3):256-9. doi: 10.2169/internalmedicine.39.256. PMID: 10772132
Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.
Montserrat E, Villamor N, Urbano-Ispizua A, Ribera JM, Lozano M, Vives-Corrons JL, Rozman C
Ann Hematol 1991 Jul;63(1):15-9. doi: 10.1007/BF01714955. PMID: 1878419
A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Blood 1990 Apr 1;75(7):1422-5. PMID: 2180493

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity